|
1
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McGuigan A, Kelly P, Turkington RC, Jones
C, Coleman HG and McCain RS: Pancreatic cancer: A review of
clinical diagnosis, epidemiology, treatment and outcomes. World J
Gastroenterol. 24:4846–4861. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Neoptolemos JP, Kleeff J, Michl P,
Costello E, Greenhalf W and Palmer DH: Therapeutic developments in
pancreatic cancer: Current and future perspectives. Nat Rev
Gastroenterol Hepatol. 15:333–348. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zeng S, Pöttler M, Lan B, Grutzmann R,
Pilarsky C and Yang H: Chemoresistance in pancreatic cancer. Int J
Mol Sci. 20:45042019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Collisson EA, Bailey P, Chang DK and
Biankin AV: Molecular subtypes of pancreatic cancer. Nat Rev
Gastroenterol Hepatol. 16:207–220. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rhim AD, Mirek ET, Aiello NM, Maitra A,
Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK,
Vonderheide RH, et al: EMT and dissemination precede pancreatic
tumor formation. Cell. 148:349–361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reichert M, Bakir B, Moreira L, Pitarresi
JR, Feldmann K, Simon L, Suzuki K, Maddipati R, Rhim AD, Schlitter
AM, et al: Regulation of epithelial plasticity determines
metastatic organotropism in pancreatic cancer. Dev Cell.
45:696–711.e8. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Canessa CM, Schild L, Buell G, Thorens B,
Gautschi I, Horisberger JD and Rossier BC: Amiloride-sensitive
epithelial Na+ channel is made of three homologous subunits.
Nature. 367:463–467. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jasti J, Furukawa H, Gonzales EB and
Gouaux E: Structure of acid-sensing ion channel 1 at 1.9 A
resolution and low pH. Nature. 449:316–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu C, Zhu LL, Xu SG, Ji HL and Li XM:
ENaC/DEG in tumor development and progression. J Cancer.
7:1888–1891. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu S, Liu C, Ma Y, Ji HL and Li X:
Potential roles of amiloride-sensitive sodium channels in cancer
development. Biomed Res Int. 2016:21902162016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Geng Y, Zhao S, Jia Y, Xia G, Li H, Fang
Z, Zhang Q and Tian R: miR95 promotes osteosarcoma growth by
targeting SCNN1A. Oncol Rep. 43:1429–1436. 2020.PubMed/NCBI
|
|
14
|
Wu L, Ling ZH, Wang H, Wang XY and Gui J:
Upregulation of SCNN1A promotes cell proliferation, migration, and
predicts poor prognosis in ovarian cancer through regulating
epithelial-mesenchymal transformation. Cancer Biother Radiopharm.
34:642–649. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jerkovic I, Ibrahim DM, Andrey G, Haas S,
Hansen P, Janetzki C, González Navarrete I, Robinson PN, Hecht J
and Mundlos S: Genome-wide binding of posterior HOXA/D
transcription factors reveals subgrouping and association with
CTCF. PLoS Genet. 13:e10065672017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pernía O, Sastre-Perona A,
Rodriguez-Antolin C, García-Guede A, Palomares-Bralo M, Rosas R,
Sanchez-Cabrero D, Cruz P, Rodriguez C, Diestro M, et al: A novel
role for the tumor suppressor gene ITF2 in tumorigenesis and
chemotherapy response. Cancers (Basel). 12:7862020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li ZG, Xiang WC, Shui SF, Han XW, Guo D
and Yan L: 11 Long noncoding RNA UCA1 functions as miR-135a sponge
to promote the epithelial to mesenchymal transition in glioma. J
Cell Biochem. 121:2447–2457. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hirao N, Iwata T, Tanaka K, Nishio H,
Nakamura M, Morisada T, Morii K, Maruyama N, Katoh Y, Yaguchi T, et
al: Transcription factor homeobox D9 is involved in the malignant
phenotype of cervical cancer through direct binding to the human
papillomavirus oncogene promoter. Gynecol Oncol. 155:340–348. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu H, Dai W, Li J, Xiang L, Wu X, Tang W,
Chen Y, Yang Q, Liu M, Xiao Y, et al: HOXD9 promotes the growth,
invasion and metastasis of gastric cancer cells by transcriptional
activation of RUFY3. J Exp Clin Cancer Res. 38:4122019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wen D, Wang L, Tan S, Tang R, Xie W, Liu
S, Tang C and He Y: HOXD9 aggravates the development of cervical
cancer by transcriptionally activating HMCN1. Panminerva Med. May
14–2020.doi: 10.23736/S0031-0808.20.03911-7 (Epub ahead of
print).
|
|
21
|
Liu X, Bing Z, Wu J, Zhang J, Zhou W, Ni
M, Meng Z, Liu S, Tian J, Zhang X, et al: Integrative gene
expression profiling analysis to investigate potential prognostic
biomarkers for colorectal cancer. Med Sci Monit.
26:e9189062020.PubMed/NCBI
|
|
22
|
Tomczak K, Czerwińska P and Wiznerowicz M:
The cancer genome atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19:A68–A77. 2015.PubMed/NCBI
|
|
23
|
GTEx Consortium: The genotype-tissue
expression (GTEx) project. Nat Genet. 45:580–585. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lacny S, Wilson T, Clement F, Roberts DJ,
Faris P, Ghali WA and Marshall DA: Kaplan-Meier survival analysis
overestimates cumulative incidence of health-related events in
competing risk settings: A meta-analysis. J Clin Epidemiol.
93:25–35. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu L, Faruqu FN, Lim YM, Lim KY, Liam-Or
R, Walters AA, Lavender P, Fear D, Wells CM, Tzu-Wen Wang J and
Al-Jamal KT: Exosome-mediated RNAi of PAK4 prolongs survival of
pancreatic cancer mouse model after loco-regional treatment.
Biomaterials. 264:1203692021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin C, Sun L, Huang S, Weng X and Wu Z:
STC2 Is a potential prognostic biomarker for pancreatic cancer and
promotes migration and invasion by inducing epithelial-mesenchymal
transition. Biomed Res Int. 2019:80424892019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ge L, Wang H, Xu X, Zhou Z, He J, Peng W,
Du F, Zhang Y, Gong A and Xu M: PRMT5 promotes
epithelial-mesenchymal transition via EGFR-β-catenin axis in
pancreatic cancer cells. J Cell Mol Med. 24:1969–1979. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang L, Wu H, Wang L, Zhang H, Lu J, Liang
Z and Liu T: Asporin promotes pancreatic cancer cell invasion and
migration by regulating the epithelial-to-mesenchymal transition
(EMT) through both autocrine and paracrine mechanisms. Cancer Lett.
398:24–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Crosby JR, Zhao C, Jiang C, Bai D, Katz M,
Greenlee S, Kawabe H, McCaleb M, Rotin D, Guo S and Monia BP:
Inhaled ENaC antisense oligonucleotide ameliorates cystic
fibrosis-like lung disease in mice. J Cyst Fibros. 16:671–680.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dirlewanger M, Huser D, Zennaro MC,
Girardin E, Schild L and Schwitzgebel VM: A homozygous missense
mutation in SCNN1A is responsible for a transient neonatal form of
pseudohypoaldosteronism type 1. Am J Physiol Endocrinol Metab.
301:E467–E473. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
D'Arcangelo D, Scatozza F, Giampietri C,
Marchetti P, Facchiano F and Facchiano A: Ion channel expression in
human melanoma samples: In silico identification and experimental
validation of molecular targets. Cancers (Basel). 11:4462019.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pastushenko I and Blanpain C: EMT
transition states during tumor progression and metastasis. Trends
Cell Biol. 29:212–226. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu M, Xiao Y, Tang W, Li J, Hong L, Dai
W, Zhang W, Peng Y, Wu X, Wang J, et al: HOXD9 promote
epithelial-mesenchymal transition and metastasis in colorectal
carcinoma. Cancer Med. 9:3932–3943. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lv X, Li L, Lv L, Qu X, Jin S, Li K, Deng
X, Cheng L, He H and Dong L: HOXD9 promotes epithelial-mesenchymal
transition and cancer metastasis by ZEB1 regulation in
hepatocellular carcinoma. J Exp Clin Cancer Res. 34:1332015.
View Article : Google Scholar : PubMed/NCBI
|
